What impact will EPPO's new resistance risk assessment guideline have on selection pressure in the European Union?

被引:1
|
作者
Leonard, PK
Dutton, R
机构
[1] BASF AG, B-1180 Brussels, Belgium
[2] DowAgrosci Ltd, Abingdon OX14 4RN, Oxon, England
关键词
resistance; risk analysis; EPPO; guideline; Europe; cost;
D O I
10.1002/ps.563
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
This paper examines practical and regulatory implications, including both costs and benefits, resulting from implementation of EPPO's new resistance risk analysis guideline. Crop-protection companies operating in Europe are preparing risk analyses and management strategies, and are monitoring for resistance. However, this is a complex and expensive process involving technical, commercial and regulatory functions. The actual cost of filling these data gaps is consequently greater than many would have anticipated. The agrochemical industry has a vested interest in managing resistance and is committed to maintaining the essential contribution of crop-protection products to sustainable agriculture. However, with increasing regulatory costs, it is important that regulatory authorities concentrate requirements for resistance risk analyses, management strategies and monitoring where these are most needed. Should these requirements be applied indiscriminately, crop-protection companies will have to consider whether or not it is economically justifiable to make these investments, or whether to remove less profitable uses from product labels. In such situations, minor crops stand to be disproportionately effected. One year after publication, it is too early to measure the guideline's impact on selection pressure. It is already clear that the guideline represents an unprecedented step forward in the regulation and harmonisation of resistance management. There are, however, valid arguments against regulation of resistance management. One of the most important criticisms that is levelled against the latter approach is that, with the best motivation and with appropriate use restrictions on labels, these actions alone do not solve the problem. It is critical that all stakeholders in the crop protection process are made aware of the importance of resistance management and of complying with prescribed strategies. (C) 2002 Society of Chemical Industry.
引用
收藏
页码:939 / 943
页数:5
相关论文
共 50 条
  • [1] The New European Union Leadership What Does it Mean for the European Union's Eastern Neighborhood?
    Ciot, Melania-Gabriela
    Damaschin, Ana
    TRANSYLVANIAN REVIEW, 2020, 29 (03): : 129 - 142
  • [2] Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001
    Straub, JO
    TOXICOLOGY LETTERS, 2002, 131 (1-2) : 137 - 143
  • [3] AN ASSESSMENT OF THE EUROPEAN UNION'S IMPACT ON RESOLUTION OF THE KOSOVO IMPASSE
    Kelkitli, Fatma Asli
    ANKARA AVRUPA CALISMALARI DERGISI-ANKARA REVIEW OF EUROPEAN STUDIES, 2018, 17 (01): : 33 - 59
  • [4] What Have We Learnt from the European Union's Emissions Trading System?
    Wrake, Markus
    Burtraw, Dallas
    Lofgren, Asa
    Zetterberg, Lars
    AMBIO, 2012, 41 : 12 - 22
  • [5] What Have We Learnt from the European Union’s Emissions Trading System?
    Markus Wråke
    Dallas Burtraw
    Åsa Löfgren
    Lars Zetterberg
    AMBIO, 2012, 41 : 12 - 22
  • [6] What's Left of the Law of Integration? Decay and Resistance in European Union Law
    Avbelj, Matej
    COMMON MARKET LAW REVIEW, 2019, 56 (05): : 1417 - +
  • [7] What's Left of the Law of Integration? Decay and Resistance in European Union Law
    Leino, Paivi
    EUROPEAN LAW REVIEW, 2019, 44 (02) : 280 - 283
  • [8] Impact assessment culture in the European Union. Time for something new?
    Saltelli, Andrea
    Kuc-Czarnecka, Marta
    Lo Piano, Samuele
    Lorincz, Mate Janos
    Olczyk, Magdalena
    Puy, Arnald
    Reinert, Erik
    Smith, Stefan Thor
    van der Sluijs, Jeroen P.
    ENVIRONMENTAL SCIENCE & POLICY, 2023, 142 : 99 - 111
  • [9] A critical assessment of the European Commission's proposals for the risk assessment and registration of chemical substances in the European Union
    Combes, R
    Dandrea, J
    Balls, M
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2003, 31 (03): : 353 - 364
  • [10] In the European Union, TB patients from former Soviet countries have a high risk of multidrug resistance
    Falzon, D.
    Infuso, A.
    Ait-Belghiti, F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (09) : 954 - 958